Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Clopidogrel, an ADP‐P2Y12 Receptor Antagonist, Is Associated With Lower Opioid Consumption and a Reduced Incidence of Delirium in Cancer Patients Receiving Chemotherapy: A Nationwide Retrospective Cohort Study in Japan

Saved in:
Bibliographic Details
Published in:Neuropsychopharmacology Reports
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868553942883893248
collection WordPress RSS
FRELIP Feed Integration
container_title Neuropsychopharmacology Reports
description
discipline_display Psychiatry and Neurology
discipline_facet Psychiatry and Neurology
format Online Article
RSS Article
genre Journal Article
id rss_article:91699
institution FRELIP
journal_source_facet Neuropsychopharmacology Reports
last_indexed 2026-06-20T21:44:45.448Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Clopidogrel, an ADP‐P2Y12 Receptor Antagonist, Is Associated With Lower Opioid Consumption and a Reduced Incidence of Delirium in Cancer Patients Receiving Chemotherapy: A Nationwide Retrospective Cohort Study in Japan
Psychiatry and Neurology
General
Psychiatry and Neurology
sub_discipline_display General
sub_discipline_facet General
subject_display Psychiatry and Neurology
General
Psychiatry and Neurology
subject_facet Psychiatry and Neurology
General
Psychiatry and Neurology
title Clopidogrel, an ADP‐P2Y12 Receptor Antagonist, Is Associated With Lower Opioid Consumption and a Reduced Incidence of Delirium in Cancer Patients Receiving Chemotherapy: A Nationwide Retrospective Cohort Study in Japan
title_alt Clopidogrel, un antagonista del receptor ADP-P2Y12, se asocia con un menor consumo de opioides y una incidencia reducida de delirio en pacientes con cáncer que reciben quimioterapia: un estudio de cohorte retrospectivo a nivel nacional en Japón
Le clopidogrel, un antagoniste du récepteur ADP-P2Y12, est associé à une consommation d'opioïdes plus faible et à une incidence réduite de délire chez les patients cancéreux recevant une chimiothérapie : une étude de cohorte rétrospective nationale au Japon
Clopidogrel, um Antagonista do Receptor ADP-P2Y12, Está Associado a Menor Consumo de Opioides e Incidência Reduzida de Delírio em Pacientes com Câncer Recebendo Quimioterapia: Um Estudo de Coorte Retrospectivo Nacional no Japão
title_auth Clopidogrel, an ADP‐P2Y12 Receptor Antagonist, Is Associated With Lower Opioid Consumption and a Reduced Incidence of Delirium in Cancer Patients Receiving Chemotherapy: A Nationwide Retrospective Cohort Study in Japan
title_es_txt Clopidogrel, un antagonista del receptor ADP-P2Y12, se asocia con un menor consumo de opioides y una incidencia reducida de delirio en pacientes con cáncer que reciben quimioterapia: un estudio de cohorte retrospectivo a nivel nacional en Japón
title_fr_txt Le clopidogrel, un antagoniste du récepteur ADP-P2Y12, est associé à une consommation d'opioïdes plus faible et à une incidence réduite de délire chez les patients cancéreux recevant une chimiothérapie : une étude de cohorte rétrospective nationale au Japon
title_full Clopidogrel, an ADP‐P2Y12 Receptor Antagonist, Is Associated With Lower Opioid Consumption and a Reduced Incidence of Delirium in Cancer Patients Receiving Chemotherapy: A Nationwide Retrospective Cohort Study in Japan
title_fullStr Clopidogrel, an ADP‐P2Y12 Receptor Antagonist, Is Associated With Lower Opioid Consumption and a Reduced Incidence of Delirium in Cancer Patients Receiving Chemotherapy: A Nationwide Retrospective Cohort Study in Japan
title_full_unstemmed Clopidogrel, an ADP‐P2Y12 Receptor Antagonist, Is Associated With Lower Opioid Consumption and a Reduced Incidence of Delirium in Cancer Patients Receiving Chemotherapy: A Nationwide Retrospective Cohort Study in Japan
title_pt_txt Clopidogrel, um Antagonista do Receptor ADP-P2Y12, Está Associado a Menor Consumo de Opioides e Incidência Reduzida de Delírio em Pacientes com Câncer Recebendo Quimioterapia: Um Estudo de Coorte Retrospectivo Nacional no Japão
title_short Clopidogrel, an ADP‐P2Y12 Receptor Antagonist, Is Associated With Lower Opioid Consumption and a Reduced Incidence of Delirium in Cancer Patients Receiving Chemotherapy: A Nationwide Retrospective Cohort Study in Japan
title_sort clopidogrel, an adp‐p2y12 receptor antagonist, is associated with lower opioid consumption and a reduced incidence of delirium in cancer patients receiving chemotherapy: a nationwide retrospective cohort study in japan
topic Psychiatry and Neurology
General
Psychiatry and Neurology
url https://onlinelibrary.wiley.com/doi/10.1002/npr2.70142?af=R